UnitedHealth Group: Buy It for the Recovery, Stay for the Satire?

By July 31, any shareholder possessing an optimistic temperament or a taste for risk had discovered that the stock lost half its value in 2025-hardly a feat for the company brochure. The sinking ship, however, may not have reached the ocean floor; further turbulence is as likely as an accountant’s love for paperwork. Should the prudent citizen cross to the opposite side of the street at the sight of UNH stock, or is there a cunning angle for the connoisseur of neglected assets?





